Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Characteristics and potentials of stem cells derived from human degenerated nucleus pulposus: potential for regeneration of the intervertebral disc

BMC Musculoskeletal DisordersBMC series – open, inclusive and trusted201718:242

https://doi.org/10.1186/s12891-017-1567-4

  • Received: 18 November 2016
  • Accepted: 9 May 2017
  • Published:
Open Peer Review reports

Abstract

Background

Eliminating the symptoms during treatment of intervertebral disc degeneration (IVDD) is only a temporary solution that does not cure the underlying cause. A biological method to treat this disorder may be possible by the newly discovered nucleus pulposus derived stem cells (NPDCs). However, the uncertain characteristics and potential of NPDCs calls for a comprehensive study.

Methods

In the present study, nucleus pulposus samples were obtained from 5 patients with IVDD undergoing discectomy procedure and NPDCs were harvested using fluorescence activated cell sorting (FACS) by the co-expression of GD2+ and Tie2+. After in vitro expansion, the properties of NPDCs were compared with those of bone marrow mesenchyme stem cells (BMSCs) from the same subjects.

Results

NPDCs performed similar properties in cell colony-forming ability, cell proliferation rate, cell cycle and stem cell gene expression similar to those of BMSCs. In addition, NPDCs could be differentiated into osteoblasts, adipocytes, and chondrocytes, and are found to be superior in chondrogenesis but inferior in adipocyte differentiation.

Conclusions

NPDCs derived from the degenerated intervertebral disc still keep the regeneration ability similar to BMSCs. Besides, the superior capacity in chondrogenesis may provide a promising cell candidate for cell-based regenerative medicine and tissue engineering in IVDD.

Keywords

  • Intervertebral disc
  • Nucleus pulposus derived stem cells
  • Biological characteristics
  • Endogenous repair
  • Cell therapy

Background

A common health problem of the general population affecting both the individual’s quality of life and the family’s economic burden is lower back pain [1]. Intervertebral disc degeneration (IVDD) has been confirmed as the primary underlying reason strongly associated with lower back pain [2, 3]. Under normal circumstances, the nucleus pulposus (NP) can maintain its homeostasis and strike a balance between damage degeneration and regeneration repair [4]. Under pathological conditions, this homeostasis is disturbed by decreasing NP cell numbers and changing cell phenotype, which eventually leads to spinal instability, disc height loss, and bulging/prolapse [5]. To date, the main treatments for IVDD are focused on eliminating the symptoms rather than restoring normal function [6]. Besides this, these treatments may have several side effects like chronic pain, adjacent segment disease, and even revision surgery [7, 8]. Thus, it is necessary to highlight the critical urgency and importance of cellular therapy in this area.

The reduction of cell number leading to decreased extracellular matrix production may result in poor IVD resilience, decreased biomechanical properties, and eventual malfunction [1, 9]. Recent advances in the field of mesenchymal stromal cells (MSCs) offer promising applications in several other fields [1012]. However, in IVDD, the harsh environment of high compressive load, acidic pH, hypoxia, hyperosmolarity, and limited nutrition makes it difficult for exogenous cells to survive and proliferate [1315]. Nonetheless, hope arises in the discovery of nucleus pulposus derived stem cells (NPDCs), which may act as a candidate for endogenous repair in NP tissue [16, 17].

In the last few years, several groups have proposed the existence of stem cells in the NP tissue [18]. At First, Risbud et al [19] demonstrated the existence of NP progenitor cells in the NP and Henriksson et al [20] then found cell proliferation zones as a potential stem cell niche in the IVD region. Afterwards,, Blanco et al [18] reported that the NPDCs hold the same characteristic as BMSCs. Subsequently, many studies have transferred the studies in demonstrating the existence of NPDCs in other species [2123]. However, whether the NPDCs from human degenerated NP tissues hold the regenerative potential urgently need to be comprehensively and systematically studied. In addition, all of previous studies reporting NPDCs were directly harvested from NP tissues which may also contain other types of cells [24]. Sakai et al [25] first reported that GD2 and Tie 2 could be used as identification markers for NPDCs. Therefore, in the present study, we obtained NPDCs by fluorescence-activated cell sorting (FACS) and compared them with BMSCs obtained from the same subject. Cell proliferation rate, colony formation ability, cell cycle, expression of stem cell genes, and the ability to differentiate into osteoblasts, adipocytes, and chondrocytes were compared between these two cell types. Through this study, we aimed to provide the molecular and cellular characterization of purified human NPDC subpopulations.

Methods

Case selection

The study was undertaken in the Department of Orthopedics of two hospitals (Navy General Hospital, Beijing, China, and Gaozhou people’s Hospital, Guangdong, China). The ethics committee of Navy General Hospital, Beijing, China and Gaozhou people’s hospital have approved this study and the procedures are in accordance with the Helsinki Declaration. Each patient enrolled in this study signed the informed consent. The NP tissue was obtained from 5 patients who underwent posterior discectomy surgery for lumbar degenerative disease. Meanwhile, bone marrow (BM) were also derived from the same patient respectively. The average age of the patients was 50.6 years (range: 45–56 years), and he details of all samples are shown in Table 1.
Table 1

Details characteristic of the enrolled patients

Case NO.

Diagnosis

Disc level

Modic type

BM(ml)

Gender

Age(year)

1

Spinal stenosis

L4-L5

II

7.0

M

54

2

Spinal stenosis

L5-S1

III

7.5

F

48

3

Spondylolisthesis

L4-L5

II

9.0

F

52

4

Lumbar disc herniation

L4-L5

I

8.5

M

45

5

Lumbar disc herniation

L5-S1

II

6.5

M

37

Histomorphometry of human degenerated NP tissue

NP tissue were fixed in 10% formalin at room temperature for 24 h, embedded in paraffin and sectioned to 5-μm-thick sections. The tissue slices were stained with H&E to indicate their histological features as described previously [26].

Isolation, sorting, and culture of NPDCs

NPDCs were isolated as previously described [25]. Briefly, human NP tissues were fragmented into pieces no larger than 1 mm3 and digested with 0.2% collagenase II (Sigma, USA)in DMEM/F12 for 6-8 h in a humidified atmosphere containing 5% CO2 at 37 °C. After centrifugation for 5 min at 1500 rpm, the pellet was cultured at a density of 106 cells/cm2 in DMEM/F12 supplemented with 10% FCS and 10 units/ml penicillin-streptomycin in a humidified atmosphere containing 5% CO2 at 37 °C. FACS analysis and purification of cells was conducted as described previously [25]. The passage 2 cells were analyzed and sorted on a FACS Vantage cell sorter (BD Biosciences) using monoclonal antibodies purchased from eBioscience (BD, USA). The GD2 (BD Pharmingen; 14; G2a, 50 TESTs) and Tie2 (R&D Systems, clone 83715, 100 TESTs) monoclonal antibodies are used for analysis and purification. The isolated cells were cultured at a density of 105 cells/cm2 in DMEM/F12 supplemented with 10% FCS and 10 units/ml penicillin-streptomycin in a humidified atmosphere containing 5% CO2 at 37 °C.

Isolation and culture of BMSCs

MSCs from bone marrow (BM) were isolated from vertebral body of the same patients as previously described [27].. Briefly, BM aspirate (5–10 ml) was collected using a syringe containing 10,000 IU of heparin to prevent coagulation. BM mononuclear cells (MNCs) were isolated by density-gradient centrifugation (Percoll solution, Sigma, USA), resuspended, and cultured as BM-MNCs. All the BM-MNCs were cultured at a density of 106 cells/cm2 in a humidified atmosphere containing 5% CO2 at 37 °C. After 48 h, non-adherent cells were removed and adherent cells were washed twice with PBS and cultured in culture medium containing DMEM/F12 supplemented with 10% FCS and 10 units/ml penicillin-streptomycin. After reaching 80% confluence, the cells were harvested with 0.25% trypsin/EDTA (HyClone, USA) for 2 min and subcultured at a ratio of 1:3.

Measurement of cell proliferation capacity

To measure the proliferation capacity, the Cell Counting Kit-8 (CCK-8, Dojindo Laboratories, Japan) and the Passage 4 (P4) cells were used as described previously [27]. Briefly, 10 μL of CCK-8 solution was added to each well of a 96-well plate containing 5000 cells. After incubating the plate at 37 °C for 4 h, absorbance at 450 nm was measured using a microplate absorbance reader (BioRad, USA). Cell proliferation was tested on days 1, 3, 5, 7, 9, 11 and 13. A blank 96-well plate was used for the zero setting. All experiments were performed thrice.

Colony-forming assay

To compare the colony-forming abilities of NPDCs and BMSCs, P4 populations were plated in cell culture dishes at various seeding densities (100 and 1000 cells/10 cm2). After culturing for 14 days, crystal violet staining was performed to count the colonies as previously described [28]. Briefly, cells were washed thrice with PBS, fixed in 4% paraformaldehyde for 15 min, stained with 0.1% crystal violet (Keygen Biotech, Beijing, China) for 15 min, and washed 3 times with PBS before counting the number of colonies. A colony containing less than 50 cells was ignored. Colony-forming efficiency was calculated by dividing the number of colonies by the initial number of adherent cells.

Cell cycle assay

For cell cycle analysis, both NPDCs and BMSCs of P4 population were fixed in 75% chilled ethanol for 72 h at 4 °C. After washing twice with PBS, 1 ml propidium iodide (PI, Invitrogen, USA) staining solution and 50 μL RNase A stock solution (Invitrogen, USA) were added and incubated at 4 °C for 3 h. Measurements were performed on a FACSCalibur flow cytometer (BD, USA) using CellQuest software (BD, USA) and acquiring 10,000 cells per sample.

Reverse transcriptase polymerase chain reaction (RT-PCR) and real-time quantitative reverse transcriptase polymerase chain reaction (qPCR) assay

Total RNA extraction was performed in both P4 cells as described previously [27]. The RT reaction (2 μL) was amplified in quadruplex by real-time PCR (ABI PRISM 7000) in a final volume of 25 μL, using the SYBR Green Master Mix reagent (Applied Biosystems, Foster City, CA). The specific primers used for stem cell genes, and osteogenic, adipogenic, and chondrogenic markers, are shown in Table 2. β-actin expression was used to normalize the expression of all the genes. For each cDNA sample, the cycle threshold (Ct) value of each target sequence was subtracted from the Ct value of the reference gene. RT-PCR was used to analyze the expression level of stem cell genes and qPCR was performed to compare the difference in the expression of osteogenic, adipogenic, and chondrogenic genes between groups of cells after induction for 4 weeks.
Table 2

The Primers for Real-Time Polymerase Chain Reaction

Target gene

Primers sequence

RUNX-2

sense 5’-ACGACAACCGCACCATGGT-3’

antisense 5’-CTGTAATCTGACTCTGTCCT-3’

alkaline phosphatase (ALP)

sense 5’-TGGAGCTTCAGA AGCTCAACACCA-3’

antisense 5’-ATCTCGTTGTCTGAGTACCAGTCC-3’

peroxisome proliferators-activated receptor 2 (PPAR-2)

sense 5’-CGAGGGCGATCTTGACAGGAA -3’

antisense 5’-CAGGGGGGTGATGTGTTTGAAC- 3’

adipogenic protein (APP)

sense 5’-CTGTCCAAGTCCAACAGCAA-3’

antisense 5’-ACGTTGGCAGCTTTACGTCT-3’

lipoprotein lipase (LPL)

sense 5’-TCCGCGTGATTGCAGAGAGAG-3’

antisense 5’-TGCTGCTTCTTTTGGCTCTGACT-3’

aggrecan (Agg)

sense 5’-TGAGGAGGGCTGGAACAAGTACC-3’

antisense 5’-GGAGGTGGTAATTGCAGGGAACA-3’

collagen II (Col II)

sense 5’-TTTCCCAGGTCAAGATGGTC-3’

antisense 5’-TCACCTGGTTTTCCACCTTC-3’

SOX-9

sense 5’-TGGCCGAGATGATCCTAAAAATAA -3’

antisense 5’-GCGCTTGGATAGGTCATGTTTGT-3’

SOX-2

sense 5’-CCCCTGTGGTTACCTCTTCCTC-3’

antisense 5’-GGCCGCTCTGGTAGTGCTG-3’

NANOG

sense 5’-ACCCCGTTTCACTGTGTTAGC-3’

antisense 5’-GACGGCAGCCAAGGTTATTAAA-3’

OCT4

sense 5’-GGCAAGCGATCAAGCAGCGAC-3’

antisense 5’-GGGAAAGGGACCGAGGAGTAC-3’

β-actin

sense 5’-GTGGGGCGCCCCAGGCACCA-3’

antisense 5’-CTTCCTTAATGTCACGCACGATTTC-3’

Western blot assay of type II collagen and aggrecan

The samples were incubated with an extraction solution containing 1 ml 4 M guanidine chloride (GuCl), 0.1 M -6-aminohexanoic acid, 20 mM –benzamidine hydrochloride, 10 mM -EDTA, 5 mM -N-ethylmaleimide and 0.5 mM phenylmethanesulfonyl fluoride, pH 5.0 at 4 °C for 3 h. GuCl extracted dialysate was resuspended in 50 ml of sample buffer and analyzed by electrophoresis on a 6% (w/v) SDS-PAGE gels. Equal amounts of protein per lane (50 μg) were loaded and separated by electrophoresis. Protein was transferred to a polyvinylidene fluoride (PVDF) membrane by electroblotting. Rinse the membrane in water and block the blotted membrane in freshly prepared PBS containing nonfat dry milk (5%) for 60 min at room temperature with constant agitation. The membrane was incubated with the human type II collagen (1:5000, Sigma, USA) and aggrecan (1:5000, Sigma, USA) antibodies overnight at 4 °C with agitation. After washed the membrane three times with PBS, the secondary goat anti-mouse horseradish peroxidase (HRP)-conjugated anti-body was added and incubated overnight at 4 °C with agitation. Subsequently, the blots were washed 5 times with PBS containing 0.05% Tween 20 and the signal of bound antibodies was developed by enhanced chemiluminescence.

Osteogenic induction and quantitation of mineral deposits

For osteogenic differentiation, 2.0 × 104 P4 cells were cultured in human MSC osteogenic differentiation medium (Cyagen Biosciences, Guangzhou, China), changed every 3 days. Cells were fixed with 4% formaldehyde and stained with Alizarin red staining (Sigma, USA) for 15 min after 21 days of culture. The cells were then stained with alizarin red for 15 min at 37 °C and washed thrice with distilled water. Finally, alizarin red staining was observed under a microscope (Leica, Germany).

Adipogenic induction and quantitation of adipogenic capacity

Adipogenic differentiation was performed in cultures using induction medium A and maintenance medium B (Cyagen Biosciences, Guangzhou, China). The detailed contents of medium A and B have been described previously [22]. First, the 2.0 × 104 P4 cells in each plate were incubated in induction medium A for 72 h, which was then replaced with maintenance medium B for 24 h. This 96 h induction-maintenance cycle was repeated four times and in the end, cells were incubated in maintenance medium B for 7 days. Cells cultured with culture medium only served as controls. To visualize the lipid-rich vacuoles in cells, oil red O staining was performed as described previously [27]. In short, cells were fixed with 4% formaldehyde and stained with oil red O for 15 min. Hematoxylin was used for nuclear staining. Finally, the cultures were extensively washed with distilled water to remove the excess stain.

Chondrogenic induction and quantitation of chondrogenic capacity

Chondrogenic differentiation was performed as described previously [22]. Briefly, 2.0 × 104 P4 cells were harvested and seeded into multi-well cell culture plates in culture medium. After 24 h, the culture medium was replaced with chondrogenic differentiation medium (Cyagen Biosciences, Guangzhou, China). Cells were treated twice weekly with fresh chondrogenic differentiation medium for 4 weeks. Cells cultured with culture medium only served as controls. The alcian blue intensity assay was performed as described previously [27]. Cells were treated twice weekly with fresh chondrogenic differentiation medium for 4 weeks. At last, cells were rinsed thrice with PBS, fixed with 4% paraformaldehyde for 15 min at room temperature, then washed with PBS, and stained with 1% alcian blue for 15 min.

Statistical analysis

Colony formation, cell proliferation, percentage of cell cycle phases, stem cell gene expression levels, and the ability to differentiate into osteoblasts, adipocytes, and chondrocytes was reported as mean ± SD (standard deviation) values. The histological and western blot data are described qualitatively and shown as images. To quantify multiple differentiation capacities by morphology, the differentiation value (DV) method was adopted [29]. Briefly, five random high power fields from one source were counted using Image-Pro Plus version 6.0 (IPP 6.0). Quantifiable data comparing NPDCs and BMSCs were analyzed using Student’s t tests. All data analyses were performed using SPSS version 15.0. p < 0.05 was regarded as statistically significant.

Results

Gross morphology and histomorphology of human degenerated NP tissue

NP was white and translucent after being cleaned and no vascular or fat tissues were observed in any of the NP tissues (Fig. 1a). The extracellular matrix (ECM) of NP tissues was homogeneous and contained round-shaped cells distributed in different layers. (Fig. 1b). Besides, a proportion of highly proliferation cells was observed in NP tissue as shown in red arrows (Fig. 1b).
Fig. 1
Fig. 1

Gross morphology and histomorphology of degenerated NP tissue. a: gross morphology; b: histologic morphology with HE staining (Bar = 100 μm)

FACS results

For the NP-derived cells from each of the 5 patients, evaluation of GD2 and Tie2 positivity was performed by FACS. The results showed the presence of a proportion of cells, which expressed GD2 and Tie2 cells (39.8 ± 27.4%, 14.07 ± 8.3% and co-expression of 7.7 ± 5.4% Fig. 2). The cells were then sorted by FACS with double positive markers and the harvested cell population were seeded at a density of 105 cells/cm2.
Fig. 2
Fig. 2

The positive expression of GD2 or Tie2 cells in degenerated NP derived cells. a: representative histogram of flow cytometry; b: cell percentage of positive expressing cells

Colony-forming abilities and proliferation capacity

Two different cell densities were seeded to test the colony-forming abilities of both cells revealing that NPDCs and BMSCs could form colonies after 2 weeks (Fig. 3a-d). With seeding densities of 100 cells/10 cm2 and 1000 cells/10 cm2, BMSCs performed better colony formation (p < 0.05, Fig. 3e). Regarding proliferation capacity, both two groups exhibited similar growth tendencies. When the OD values were measured, a continuous increase was observed from day 1 to day 13 and a plateau period was formed from day 7–13. However, a slightly higher proliferation capacity was found in BMSCs at the last 4 time points (p < 0.05, Fig. 3f).
Fig. 3
Fig. 3

Colony formation and proliferation of NPDCs and BMSCs. The colonies stained with crystal violet at 13 days (a, c: NPDCs; b, d: BMSCs). Colony formation assay for NPDCs and BMSCs (e). The proliferation capacity of BMSCs and NPDCs measured by the CCK-8 assay (f). * p < 0.05. Data represents cells derived from 5 different patients (mean ± SD)

Stem cell gene analysis

OCT-4, NANOG, and SOX-2 are genes that are commonly expressed in stem cells. Both NPDCs and BMSCs were used to determine the expression of these genes and the results were similar in PT-PCR evaluation (Fig. 4a). In qPCR analysis, NPDCs showed gene expression levels that were comparable with those of BMSCs (p >0.05, Fig. 4b).
Fig. 4
Fig. 4

Stem cell genes (OCT-4, NANOG, and SOX-2) were expressed in both NPDCs and BMSCs. a: RT-PCR; b: qPCR

Cell cycle assay

The percentage of cells in each phase of the cell cycle was analyzed by flow cytometry. Cell cycle analysis was conducted by measuring the DNA content from both stem cells. Approximately 90% of the NPDCs and BMSCs were in the G0/G1 phase (88.62% vs. 91.35%), and no significant differences were detected between both groups in this criterion(p > 0.05, Fig. 5).
Fig. 5
Fig. 5

Cell cycle analysis of NPDCs and BMSCs. The cell cycle histograms of NPDCs and BMSCs are shown (a). There were no significant differences in G0/G1 cell cycle phases between the NPDCs and BMSCs (b). Data represents cells derived from 5 different patients (mean ± SD)

Osteogenic induction and related quantitative assays

Osteogenic differentiation was confirmed by the deposition of an alizarin red positive mineralized matrix. From the morphology observed, the area percentage showed of no difference between the two groups after 4 weeks induction (Fig. 6a-d). The positively stained mineralized nodules in the NPDC group were larger and the qPCR analysis showed no significant difference in the expression of RUNX-2 and ALP genes between groups after 4 weeks(p >0.05, Fig. 6e, f). However, expression of the OC gene in the NPDCs was slightly higher (p < 0.05, Fig. 6f).
Fig. 6
Fig. 6

Osteogenic differentiation of NPDCs and BMSCs stained with alizarin red after 4 weeks. a: NPDCs; b: BMSCs; c: NPDCs after 4 weeks osteogenic induction; d: BMSCs after 4 weeks osteogenic induction. Quantitative analysis of mineral deposition in both cell types cultured in osteogenic medium showed no difference after 4 weeks (e). Higher expression levels were observed for OC mRNA in NPDCs, whereas no significant difference was observed in ALP and RUNX2 expression after 4-week induction (f). * p < 0.05. Data represents cells derived from 5 different patients (mean ± SD)

Adipogenic differentiation and related quantitative assays

The observation of lipid-rich vacuoles stained with oil red O was used to evaluate adipogenic ability. Both cell types exhibited intracellular lipid vacuoles after 4 weeks of induction. The area that was positive for oil red O accumulated and superior adipogenic differentiation capability was detected in BMSCs after 4 weeks (p < 0.05, Fig. 7a-e). In addition, qPCR analysis of adipogenic mRNA (PPAR-2, LPP, and APP) showed higher expression of PPAR-2 and LPP in BMSCs (Fig. 7f).
Fig. 7
Fig. 7

Adipogenic differentiation of NPDCs and BMSCs stained with oil red O after 4 weeks. a: NPDCs; b: BMSCs; c: NPDCs after 4 weeks adipogenic induction; d: BMSCs after 4 weeks adipogenic induction. Quantitative analysis of lipid-rich vacuoles in both two cell types showed superior adipogenic potential in BMSCs e The mRNA levels of adipogenic genes showed lower expression levels of LPP and PPAR2 in NPDCs after 4-week induction compared with BMSCs (f). * p < 0.05. Data represents cells derived from 5 different patients (mean ± SD)

Chondrogenic differentiation and related quantitative assays

For in vitro chondrogenesis, the Alcian blue intensity assay was performed to evaluate chondrogenic potential. The area that was positive for Alcian blue from NPDCs were larger than BMSCs after 4 weeks of induction (p < 0.05, Fig. 8a-e). Regarding the expression of chondrogenic genes, higher mRNA expression levels of collagen IIα1 and aggrecan were observed in NPDCs after 4 weeks of induction (Fig. 8g). Western blot analysis indicated that both Collagen II (Col II) and aggrecan (agg) protein levels were higher in NPDCs, which was in accordance with qPCR results (Fig. 8f).
Fig. 8
Fig. 8

Chondrogenic differentiation of NPDCs and BMSCs stained with Alcian blue after 4 weeks. a: NPDCs; b: BMSCs; c: NPDCs after 4 weeks chondrogenic induction; d: BMSCs after 4 weeks chondrogenic induction. Larger positive alcian blue area were detected in NPDCs after 4 weeks chondrogenic induction (e) and Higher mRNA expression level of Collagen IIα1and Aggrecan were observed in NPDCs after 4-week induction g Higher Col II and aggrecan protein levels were found by western blotting in NPDCs (f). *p < 0.05. Data represents cells derived from 5 different patients (mean ± SD)

Discussion

This report describes the isolation of human NPDCs by FACS and their comprehensive in vitro characterization compared to those of BMSCs. Thus, the results of this study may play a helpful role in intervertebral disc tissue engineering and regeneration. In this study, the morphology, proliferation potential, colony formation ability, cell cycle, stem cell gene expression, and potential for multiple lineage differentiation were assessed for NPDCs and BMSCs from the same subjects. Our study reveals that the sorted NPDCs possess the same characteristics as those of BMSCs in most respects but show superior ability for chondrogenic differentiation in vitro. These findings provide comprehensive evidence of a new cell resource with more prospects in IVDD tissue engineering.

Our study is based on previous other studies describing the presence of stem cells derived from NP tissue [18, 19, 22, 23, 3032]. However, studies on the cell characteristics and potential of these cells are lacking. Although NPDCs are proposed as a valid and promising cell source in disc regenerated tissue engineering, sufficient evidence for this is crucially needed. Additionally, all the published studies were focused on the existence of NPDCs by directly harvesting them from the NP tissue [18, 20, 23, 30, 32, 33], which is possibly a mixture of impure and polymictic cells. In this study, we isolated NPDCs through FACS and expanded these cells in vitro [26]. Therefore, our stem cells were purified and credible.

Currently, MSCs are confirmed according to the guidelines of the International Society for Cellular Therapy (ISCT) [34], which include in vitro adherence to plastic surfaces, immunophenotypic profile, and multilineage differentiation capacity into osteogenic, adipogenic, and chondrogenic lineages. However, with respect to immunophenotypic profile, it is not known whether the stem cells derived from NP would conform to these requirements. Therefore, due to lack of specific immunophenotypic profile of NPDCs, all previously reported NPDCs were considered by ISCT as the reference standard. In this study, NPDCs were sorted by FACS, and so the immunophenotypic profile of the cells included the expression of GD2 and Tie2, which was reported to be more suitable for NPDCs [25]. Moreover, because ISCT criteria for defining MSCs is minimal and limited, several other potential abilities were additionally tested for a comprehensive evaluation in this study.

From gross morphology, NP retrieved samples showed white gelatin tissue without other potential sources like vascular or fat cells ensuring that other potential cells were excluded. Meanwhile, from the histological aspect, a proportion of highly proliferating cells was observed in NP tissue as shown with red arrows. This is in accordance with the reports demonstrating that the cell clusters attempting to restore matrix synthesis and mechanical function performed according to the characteristics of stem cells [20, 22, 35].

NPDCs adhered to the plastic surface of a tissue culture flask and were morphologically similar to BMSCs. However, the BMSCs showed slightly superior performance with respect to proliferation capacity and colony-forming abilities. Because the NPDCs used in this study were all harvested from the degenerated NP, it is possible that cell characteristics and potential was affected to some extent. Considering these data, we may conclude that NPDCs presented with similar stem cell properties as those of BMSCs, thus providing evidence for the presence of stem cells in degenerated NP and revealing the potential ability of this new source of stem cells.

In addition, NPDCs and BMSCs shared the same cell cycle characteristics and stem cell gene expression. It is reported that the vast majority of primitive progenitor cells reside in the G0/G1 phase [36]. In our study, the cell cycle assays showed that the major percentage of cells in both cell types were in the G0/G1 phase and less than 10% of the cells were in the S and G2 + M phases. Stem cell genes like OCT-4, NANOG, and SOX-2 are reported to be highly expressed in pluripotent cells and are considered as markers of primitive stem cells [37]. Thus, the equal expression of all three genes in both cell types indicated their similarity in this aspect.

Although NPDCs shared many characteristics with BMSCs, it is believed that adult MSCs originating from a certain tissue preferentially differentiate into the type of cells residing in this tissue [38, 39]. Our results are also in accordance with these findings. In osteogenic differentiation, although qPCR results showed that NPDCs had higher expression of OC mRNA, which is considered as a marker of mature osteoblasts [40], the positively stained area at different induction times showed no difference between both groups. Therefore, this result suggests that both cells have the same osteogenic induction potential.

Regarding adipogenic capacity, BMSCs exhibited a better adipogenic capacity than NPDCs both in DV assay and in qPCR analysis. LPP and PPAR2 expression levels were significantly higher in BMSCs after 3 and 4 weeks of induction. These findings were also supported by the previous study [18].

Finally, we quantitatively evaluated the chondrogenic potential of NPDCs and BMSCs. qPCR analysis showed higher expression of matrix transcripts (collagen II and aggrecan) in NPDCs. Furthermore, western blot indicated that protein expression of both Col II and aggrecan was higher in NPDCs, which was in accordance with the qPCR results. In conclusion, all the results demonstrated that NPDCs had a better chondrogenic potential than BMSCs.

The degenerated NP might contain a substantial amount of inflammation factors and cytokines that could have probably affected the cell properties in this study [41]. Moreover, the microenvironmental factors in the degenerated NP tissue and culture medium may affect the cell state and phenotype in some extend. Additionally, the NP samples used in our study were degenerated, and must have some difference in comparison with normal samples. Furthermore, considering this study was performed in vitro, the interactions between stem cells and their surrounding niche in vivo may affect the result of this study.

Conclusions

In conclusion, this study reports the isolation of NPDCs from degenerated human NP and their comparison with BMSCs. NPDCs derived from the degenerated intervertebral disc still keep the regeneration ability similar to BMSCs. Based on this, an investigation into the characteristics and potential of NPDCs may provide a promising cell candidate for IDD regenerative medicine.

Abbreviations

Agg: 

Aggrecan

ALP: 

Alkaline phosphatase

APP: 

Adipogenic protein

BM: 

Bone marrow

BM-MNCs: 

BM mononuclear cells

BMSCs: 

Bone marrow mesenchymal stem cells

CCK-8: 

Cell counting Kit-8

Col II: 

Collagen II

Ct: 

Cycle threshold

DMEM: 

Dulbecco’s modified eagle’smedium

DV: 

Differentiation value

ECM: 

Extracellular matrix

ECM: 

Extracellular matrix

FACS: 

Fluorescence-activated cell sorting

FCS: 

Fetal calf serum

FITC: 

Fluorescein isothiocyanate

IDD: 

Intervertebral disc degeneration

ISCT: 

International society for cellular therapy

LPL: 

Lipoprotein lipase

MSCs: 

Mesenchymal stromal cells

NP: 

Nucleus pulposus

NPDCs: 

Nucleus pulposus derived stem cells

OC: 

Osteocalcin

OD: 

optical density

PBS: 

Phosphate-buffered saline

PE: 

Phycoerythrin

PPAR-2: 

Peroxisome proliferators-activated receptor 2

SOX-9: 

SRY-box 9

Declarations

Acknowledgement

The authors wish to thank lulu Liu of pathology department of Navy General Hospital for her invaluable help in providing assistance in histologic staining.

Funding

This study was supported by National Natural Science Foundation of China. (81470102; 81171740).

Availability of data and materials

The detail information used and analyzed for the current study are available from the corresponding author on reasonable request.

Authors’ contributions

LXC wrote the main manuscript text and LXC, TY performed all the experiments. WJH, YPS, WDL and RDK directed the experiments and contributed to the discussion of the results. All authors reviewed the manuscript and all authors have given approval to the final version of the manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

All patients involved in the present study had read and signed the informed consent. The study was approved by the governing human research ethics committee in Navy General Hospital, Beijing, China, and Gaozhou people’s hospital, Guangdong, China.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Orthopaedic Surgery, Navy General Hospital, Beijing, 100048, China
(2)
Department of Orthopedic Surgery, Gaozhou people’s Hospital, No 89, Xi-Guan Road, Guangdong, Guangzhou, 525200, China

References

  1. Sakai D, Grad S. Advancing the cellular and molecular therapy for intervertebral disc disease. Adv Drug Deliv Rev. 2015;84:159–71.View ArticlePubMedGoogle Scholar
  2. DePalma MJ, Ketchum JM, Saullo T. What is the source of chronic low back pain and does age play a role? Pain Med. 2011;12(2):224–33.View ArticlePubMedGoogle Scholar
  3. Laplante BL, Ketchum JM, Saullo TR, DePalma MJ. Multivariable analysis of the relationship between pain referral patterns and the source of chronic low back pain. Pain Physician. 2012;15(2):171–8.PubMedGoogle Scholar
  4. Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ, Hoyland JA. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans. 2007;35(Pt 4):652–5.PubMedGoogle Scholar
  5. Ito K, Creemers L. Mechanisms of intervertebral disk degeneration/injury and pain: a review. Global Spine J. 2013;3(3):145–52.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Phillips FM, Slosar PJ, Youssef JA, Andersson G, Papatheofanis F. Lumbar spine fusion for chronic low back pain due to degenerative disc disease: a systematic review. Spine. 2013;38(7):E409–22.View ArticlePubMedGoogle Scholar
  7. YU Weiyang HD, LIU Feijun. Comparison of the mid- and long-term clinical outcomes of Minimally invasive versus open Transforaminal Lumbar Interbody Fusion in treatment of one-level lumbar degenerative disease. Zhejiang Journal of Traumatic Surgery. 2015;2015(2). [Epub ahead of print]Google Scholar
  8. Adogwa O, Carr K, Thompson P, Hoang K, Darlington T, Perez E, Fatemi P, Gottfried O, Cheng J, Isaacs RE. A prospective, multi-institutional comparative effectiveness study of lumbar spine surgery in morbidly obese patients: does minimally invasive transforaminal lumbar interbody fusion result in superior outcomes? World Neurosurg. 2015;83(5):860–6.View ArticlePubMedGoogle Scholar
  9. Nukaga T, Sakai D, Tanaka M, Hiyama A, Nakai T, Mochida J. Transplantation of activated nucleus pulposus cells after cryopreservation: efficacy study in a canine disc degeneration model. Eur Cell Mater. 2016;31:95–106.View ArticlePubMedGoogle Scholar
  10. Hawkey CJ, Allez M, Clark MM, Labopin M, Lindsay JO, Ricart E, Rogler G, Rovira M, Satsangi J, Danese S, et al. Autologous hematopoetic stem cell transplantation for Refractory crohn disease: a randomized clinical trial. JAMA. 2015;314(23):2524–34.View ArticlePubMedGoogle Scholar
  11. Tatullo M, Falisi G, Amantea M, Rastelli C, Paduano F, Marrelli M. Dental pulp stem cells and human periapical cyst mesenchymal stem cells in bone tissue regeneration: comparison of basal and osteogenic differentiated gene expression of a newly discovered mesenchymal stem cell lineage. J Biol Regul Homeost Agents. 2015;29(3):713–8.PubMedGoogle Scholar
  12. Zekri AR, Salama H, Medhat E, Musa S, Abdel-Haleem H, Ahmed OS, Khedr HA, Lotfy MM, Zachariah KS, Bahnassy AA. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency. Stem Cell Res Ther. 2015;6:118.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Han B, Wang HC, Li H, Tao YQ, Liang CZ, Li FC, Chen G, Chen QX. Nucleus pulposus mesenchymal stem cells in acidic conditions mimicking degenerative intervertebral discs give better performance than adipose tissue-derived mesenchymal stem cells. Cells Tissues Organs. 2014;199(5-6):342–52.View ArticlePubMedGoogle Scholar
  14. Chan SC, Gantenbein-Ritter B. Intervertebral disc regeneration or repair with biomaterials and stem cell therapy--feasible or fiction? Swiss Med Wkly. 2012;142:w13598.PubMedGoogle Scholar
  15. Huang YC, Leung VY, Lu WW, Luk KD. The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc. Spine J. 2013;13(3):352–62.View ArticlePubMedGoogle Scholar
  16. Li Z, Peroglio M, Alini M, Grad S. Potential and limitations of intervertebral disc endogenous repair. Curr Stem Cell Res Ther. 2015;10(4):329–38.View ArticlePubMedGoogle Scholar
  17. Grad S, Peroglio M, Li Z, Alini M. Endogenous cell homing for intervertebral disk regeneration. J Am Acad Orthop Surg. 2015;23(4):264–6.View ArticlePubMedGoogle Scholar
  18. Blanco JF, Graciani IF, Sanchez-Guijo FM, Muntion S, Hernandez-Campo P, Santamaria C, Carrancio S, Barbado MV, Cruz G, Gutierrez-Cosio S, et al. Isolation and characterization of mesenchymal stromal cells from human degenerated nucleus pulposus: comparison with bone marrow mesenchymal stromal cells from the same subjects. Spine. 2010;35(26):2259–65.View ArticlePubMedGoogle Scholar
  19. Risbud MV, Guttapalli A, Tsai TT, Lee JY, Danielson KG, Vaccaro AR, Albert TJ, Gazit Z, Gazit D, Shapiro IM. Evidence for skeletal progenitor cells in the degenerate human intervertebral disc. Spine. 2007;32(23):2537–44.View ArticlePubMedGoogle Scholar
  20. Henriksson H, Thornemo M, Karlsson C, Hagg O, Junevik K, Lindahl A, Brisby H. Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region: a study in four species. Spine. 2009;34(21):2278–87.View ArticlePubMedGoogle Scholar
  21. Zhang H, Ma X, Zhang L, Guan X, Bai T, Xue C. The ability to form cartilage of NPMSC and BMSC in SD rats. Int J Clin Exp Med. 2015;8(4):4989–96.PubMedPubMed CentralGoogle Scholar
  22. Shi R, Wang F, Hong X, Wang YT, Bao JP, Cai F, Wu XT. The presence of stem cells in potential stem cell niches of the intervertebral disc region: an in vitro study on rats. Eur Spine J. 2015;24(11):2411–24.View ArticlePubMedGoogle Scholar
  23. Erwin WM, Islam D, Eftekarpour E, Inman RD, Karim MZ, Fehlings MG. Intervertebral disc-derived stem cells: implications for regenerative medicine and neural repair. Spine. 2013;38(3):211–6.View ArticlePubMedGoogle Scholar
  24. van den Akker GG, Surtel DA, Cremers A, Rodrigues-Pinto R, Richardson SM, Hoyland JA, van Rhijn LW, Welting TJ, Voncken JW. Novel immortal human cell lines reveal subpopulations in the nucleus pulposus. Arthritis Res Ther. 2014;16(3):R135.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Sakai D, Nakamura Y, Nakai T, Mishima T, Kato S, Grad S, Alini M, Risbud MV, Chan D, Cheah KS, et al. Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc. Nat Commun. 2012;3:1264.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Zhang Y, Tao H, Gu T, Zhou M, Jia Z, Jiang G, Chen C, Han Z, Xu C, Wang D, et al. The effects of human Wharton’s jelly cell transplantation on the intervertebral disc in a canine disc degeneration model. Stem Cell Res Ther. 2015;6:154.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Liu LT, Huang B, Li CQ, Zhuang Y, Wang J, Zhou Y. Characteristics of stem cells derived from the degenerated human intervertebral disc cartilage endplate. PLoS ONE. 2011;6(10):e26285.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res. 2007;327(3):449–62.View ArticlePubMedGoogle Scholar
  29. Rebelatto CK, Aguiar AM, Moretao MP, Senegaglia AC, Hansen P, Barchiki F, Oliveira J, Martins J, Kuligovski C, Mansur F, et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med. 2008;233(7):901–13.View ArticleGoogle Scholar
  30. Shen Q, Zhang L, Chai B, Ma X. Isolation and characterization of mesenchymal stem-like cells from human nucleus pulposus tissue. Sci China Life Sci. 2015;58(5):509–11.View ArticlePubMedGoogle Scholar
  31. Chen X, Zhu L, Wu G, Liang Z, Yang L, Du Z. A comparison between nucleus pulposus-derived stem cell transplantation and nucleus pulposus cell transplantation for the treatment of intervertebral disc degeneration in a rabbit model. Int J Surg. 2016;28:77–82.View ArticlePubMedGoogle Scholar
  32. Wang H, Zhou Y, Chu TW, Li CQ, Wang J, Zhang ZF, Huang B. Distinguishing characteristics of stem cells derived from different anatomical regions of human degenerated intervertebral discs. Eur Spine J. 2016;25(9):2691–704.View ArticlePubMedGoogle Scholar
  33. Tao Y, Zhou X, Liang C, Li H, Han B, Li F, Chen Q. TGF-beta3 and IGF-1 synergy ameliorates nucleus pulposus mesenchymal stem cell differentiation towards the nucleus pulposus cell type through MAPK/ERK signaling. Growth Factors. 2015;1–11.Google Scholar
  34. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.View ArticlePubMedGoogle Scholar
  35. Ciapetti G, Granchi D, Devescovi V, Leonardi E, Greggi T, Di Silvestre M, Baldini N. Ex vivo observation of human intervertebral disc tissue and cells isolated from degenerated intervertebral discs. Eur Spine J. 2012;21 Suppl 1:S10–9.View ArticlePubMedGoogle Scholar
  36. Reems JA, Torok-Storb B. Cell cycle and functional differences between CD34+/CD38hi and CD34+/38lo human marrow cells after in vitro cytokine exposure. Blood. 1995;85(6):1480–7.PubMedGoogle Scholar
  37. Carlin R, Davis D, Weiss M, Schultz B, Troyer D. Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol. 2006;4(1):8.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells. 2007;25(3):750–60.View ArticlePubMedGoogle Scholar
  39. Fang B, Li N, Song Y, Lin Q, Zhao RC. Comparison of human post-embryonic, multipotent stem cells derived from various tissues. Biotechnol Lett. 2009;31(7):929–38.View ArticlePubMedGoogle Scholar
  40. Lian JB, Stein GS, Stein JL, van Wijnen AJ. Osteocalcin gene promoter: unlocking the secrets for regulation of osteoblast growth and differentiation. J Cell Biochem Suppl. 1998;30–31:62–72.View ArticlePubMedGoogle Scholar
  41. Li XC, Wu YH, Bai XD, Ji W, Guo ZM, Wang CF, He Q, Ruan DK. BMP7-based functionalized self-assembling peptides protect nucleus pulposus-derived stem cells from apoptosis In Vitro. Tissue Eng Part A. 2016;22(19-20):1218–28.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement